These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 28911865)

  • 1. 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) ameliorated dexamethasone induced hepatic gluconeogenesis through activation of Akt/FoxO1 pathway.
    Shi Y; Qiao J; Mu B; Zuo B; Yuan J
    Biochem Biophys Res Commun; 2017 Nov; 493(1):286-290. PubMed ID: 28911865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
    Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
    Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis.
    Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y
    Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological characterization of 3-(2-amino-ethyl)-5-[3-(4-butoxyl-phenyl)-propylidene]-thiazolidine-2,4-dione (K145) as a selective sphingosine kinase-2 inhibitor and anticancer agent.
    Liu K; Guo TL; Hait NC; Allegood J; Parikh HI; Xu W; Kellogg GE; Grant S; Spiegel S; Zhang S
    PLoS One; 2013; 8(2):e56471. PubMed ID: 23437140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geniposide and Gentiopicroside Suppress Hepatic Gluconeogenesis via Regulation of AKT-FOXO1 Pathway.
    Yang SQ; Chen YD; Li H; Hui X; Gao WY
    Arch Med Res; 2018 Jul; 49(5):314-322. PubMed ID: 30409503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DMT efficiently inhibits hepatic gluconeogenesis by regulating the Gαq signaling pathway.
    Zhou TT; Ma F; Shi XF; Xu X; Du T; Guo XD; Wang GH; Yu L; Rukachaisirikul V; Hu LH; Chen J; Shen X
    J Mol Endocrinol; 2017 Aug; 59(2):151-169. PubMed ID: 28637808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mibefradil reduces hepatic glucose output in HepG2 cells via Ca
    Ying D; Mengya S; Peilin L; Lingong Z; Huan M; Jing X; Le Z; Kebin Z; Bin C; Jun Y; Shaodong G; Zihui X
    Eur J Pharmacol; 2021 Sep; 907():174296. PubMed ID: 34224697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
    Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
    Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside Rg1 Inhibits Glucagon-Induced Hepatic Gluconeogenesis through Akt-FoxO1 Interaction.
    Liu Q; Zhang FG; Zhang WS; Pan A; Yang YL; Liu JF; Li P; Liu BL; Qi LW
    Theranostics; 2017; 7(16):4001-4012. PubMed ID: 29109794
    [No Abstract]   [Full Text] [Related]  

  • 11. Type I neuregulin1α is a novel local mediator to suppress hepatic gluconeogenesis in mice.
    Arai T; Ono Y; Arimura Y; Sayama K; Suzuki T; Shinjo S; Kanai M; Abe SI; Semba K; Goda N
    Sci Rep; 2017 Feb; 7():42959. PubMed ID: 28218289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin F
    Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
    Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bioinformatics and transcriptomics based investigation reveals an inhibitory role of Huanglian-Renshen-Decoction on hepatic glucose production of T2DM mice via PI3K/Akt/FoxO1 signaling pathway.
    Wu F; Shao Q; Xia Q; Hu M; Zhao Y; Wang D; Fang K; Xu L; Zou X; Chen Z; Chen G; Lu F
    Phytomedicine; 2021 Mar; 83():153487. PubMed ID: 33636476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of gluconeogenesis in primary hepatocytes by stromal cell-derived factor-1 (SDF-1) through a c-Src/Akt-dependent signaling pathway.
    Liu HY; Wen GB; Han J; Hong T; Zhuo D; Liu Z; Cao W
    J Biol Chem; 2008 Nov; 283(45):30642-9. PubMed ID: 18786922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resveratrol attenuates dapagliflozin-induced renal gluconeogenesis
    Sun X; Cao Z; Ma Y; Shao Y; Zhang J; Yuan G; Guo X
    Food Funct; 2021 Feb; 12(3):1207-1218. PubMed ID: 33432947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss.
    Marinho R; Ropelle ER; Cintra DE; De Souza CT; Da Silva AS; Bertoli FC; Colantonio E; D'Almeida V; Pauli JR
    J Cell Physiol; 2012 Jul; 227(7):2917-26. PubMed ID: 21938726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ANGPTL8/betatrophin alleviates insulin resistance via the Akt-GSK3β or Akt-FoxO1 pathway in HepG2 cells.
    Rong Guo X; Li Wang X; Chen Y; Hong Yuan Y; Mei Chen Y; Ding Y; Fang J; Jiao Bian L; Sheng Li D
    Exp Cell Res; 2016 Jul; 345(2):158-67. PubMed ID: 26387753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding.
    Jang H; Lee GY; Selby CP; Lee G; Jeon YG; Lee JH; Cheng KK; Titchenell P; Birnbaum MJ; Xu A; Sancar A; Kim JB
    Nat Commun; 2016 Jul; 7():12180. PubMed ID: 27412556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D Deficiency Induces Insulin Resistance and Re-Supplementation Attenuates Hepatic Glucose Output via the PI3K-AKT-FOXO1 Mediated Pathway.
    Mutt SJ; Raza GS; Mäkinen MJ; Keinänen-Kiukaanniemi S; Järvelin MR; Herzig KH
    Mol Nutr Food Res; 2020 Jan; 64(1):e1900728. PubMed ID: 31797544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of SphK2 Stimulated Hepatic Gluconeogenesis Associated with Dephosphorylation and Deacetylation of STAT3.
    Yuan J; Qiao J; Mu B; Lin L; Qiao L; Yan L; Shi Y
    Arch Med Res; 2018 Jul; 49(5):335-341. PubMed ID: 30448236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.